2.18
price down icon1.58%   -0.035
after-market Dopo l'orario di chiusura: 2.15 -0.03 -1.38%
loading

In 8 Bio Inc Azioni (INAB) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
2.73%
0.107
0.11 0.064 0.023 0.06
Operating Expenses
8.11%
5.201
5.66 6.224 7.109 8.689
Benefits Costs and Expenses
8.11%
5.201
5.66 11.78 7.109 8.689
Costs And Expenses
8.11%
5.201
5.66 6.224 7.109 8.689
Operating Income/Loss
8.22%
-5.094
-5.55 -6.16 -7.086 -8.629
Income/Loss From Continuing Operations Before Tax
8.22%
-5.094
-5.55 -11.71 -7.086 -8.629
Income/Loss From Continuing Operations After Tax
8.22%
-5.094
-5.55 -6.16 -7.086 -8.629
Net Income/Loss
8.22%
-5.094
-5.55 -6.16 -7.086 -8.629
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
95.07%
4.1192
83.48 7.8564 47.32 45.13
Diluted Average Shares
95.07%
4.1192
83.48 7.8564 47.32 45.13
Basic Earnings Per Share
1,671%
-1.24
-0.07 -0.04 -0.15 -0.19
Diluted Earnings Per Share
1,671%
-1.24
-0.07 -0.04 -0.15 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):